Management of Cardiac and Pulmonary Conditions in Elderly Patients

Initial Assessment and Stabilization

The American Heart Association recommends assessing for signs of hemodynamic instability, including hypotension, worsening hypoxia, or altered mental status, in patients with multiple high-risk cardiac and pulmonary conditions 3, 4
The European Society of Cardiology suggests obtaining a 12-lead ECG immediately to evaluate trifascicular block and bradycardia, which indicates high risk for complete heart block 5
Providing supplemental oxygen to maintain saturation >92% is recommended due to pulmonary hypertension and tuberculosis 4
The European Heart Journal recommends considering pain relief with morphine for chest discomfort if ischemic in nature, titrated according to severity 4

The American Heart Association recommends avoiding medications that can worsen bradycardia, such as beta-blockers and non-dihydropyridine calcium channel blockers 3

The American Thoracic Society recommends collecting three sputum samples for AFB smear, culture, and drug susceptibility testing before initiating treatment 2
The Centers for Disease Control and Prevention suggests starting standard four-drug anti-tuberculosis therapy with isoniazid, rifampin, pyrazinamide, and ethambutol for 6 months 1, 2
The American Journal of Respiratory and Critical Care Medicine recommends monitoring liver function at baseline and regularly during treatment due to potential hepatotoxicity 6, 7

The National Institute for Health and Care Excellence recommends adjusting medication dosages based on renal function, as advanced age and potential cardiac disease may affect kidney function 7
The British Thoracic Society suggests monitoring for drug interactions, particularly with any medications the patient may be taking for cardiac conditions 7

The American College of Chest Physicians recommends scheduling monthly clinical evaluations to assess treatment response and monitor for adverse effects 2
The American Heart Association suggests performing serial ECGs to monitor cardiac conduction abnormalities 5
The Centers for Disease Control and Prevention recommends repeating chest imaging after 2 months of treatment to evaluate radiographic response 2
The World Health Organization suggests monitoring for worsening of pulmonary hypertension, which is associated with worse outcomes in TB patients 8, 2

The Centers for Disease Control and Prevention recommends never adding a single drug to a failing TB regimen, as this can lead to resistance to the added drug 2
The American Thoracic Society suggests being vigilant for drug-induced hepatotoxicity, especially in elderly patients, and monitoring for symptoms such as nausea, vomiting, abdominal pain, or jaundice 6
The European Respiratory Society recommends considering potential drug interactions between TB medications and any cardiac medications the patient may require 7